Cas No. 903550-26-5, [1-(Tetrahydropyran-2-yl)-1H-pyrazol-5-yl]boronic Acid Pinacol Ester

Darolutamide, a potent androgen receptor inhibitor, has shown remarkable efficacy in the treatment of non-metastatic castration-resistant prostate cancer. Our high-quality intermediates ensure a seamless production process, enabling a steady and reliable supply of this life-changing medication. Partner with us to bring this innovative treatment to patients, making a significant impact on prostate cancer care worldwide. Embrace the opportunity to revolutionize the field of prostate cancer treatment with Darolutamide.